118 related articles for article (PubMed ID: 21327899)
41. [Treatment of advanced testicular cancer and toxicity of chemotherapy].
Kawakita M; Matsuda T; Terachi T; Yoshida O
Hinyokika Kiyo; 1999 Nov; 45(11):783-6. PubMed ID: 10637744
[TBL] [Abstract][Full Text] [Related]
42. [Long-term results of multimodality therapy of testicular germ cell tumor].
Wang JW; Yang L; Wang JY; Qu T; Cai RG; Huang J; Sun Y
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):382-5. PubMed ID: 12921572
[TBL] [Abstract][Full Text] [Related]
43. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
[TBL] [Abstract][Full Text] [Related]
44. Poor-risk testicular cancer and high-dose chemotherapy.
Motzer RJ; Sheinfeld S
J Clin Oncol; 2003 Nov; 21(22):4073-4. PubMed ID: 14568986
[No Abstract] [Full Text] [Related]
45. Post-chemotherapy residual mass in stage IIC seminomatous testicular tumor.
Ahmad NA; Biyabani SR; Abbas F
J Pak Med Assoc; 2002 Dec; 52(12):576-8. PubMed ID: 12627908
[No Abstract] [Full Text] [Related]
46. Myths and facts on adjuvant carboplatin for stage I seminoma.
Aparicio J; Germà JR
J Clin Oncol; 2006 Jul; 24(21):e40. PubMed ID: 16849740
[No Abstract] [Full Text] [Related]
47. Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer.
Kleinschmidt K; Dieckmann KP; Georgiew A; Loy V; Weissbach L
Oncology; 2009; 77(1):33-9. PubMed ID: 19440001
[TBL] [Abstract][Full Text] [Related]
48. Testicular cancer and platinum: a double-edged sword.
O'Reilly A; MacEneaney P; Mayer N; O'Reilly SP; Power DG
J Clin Oncol; 2014 Apr; 32(12):e46-8. PubMed ID: 24449237
[No Abstract] [Full Text] [Related]
49. Adjuvant therapy for stage I testicular cancer.
Cullen M; James N
Cancer Treat Rev; 1996 Jul; 22(4):253-64. PubMed ID: 9025783
[No Abstract] [Full Text] [Related]
50. Minimizing toxicity in early-stage testicular cancer treatment.
Singhera M; Lees K; Huddart R; Horwich A
Expert Rev Anticancer Ther; 2012 Feb; 12(2):185-93. PubMed ID: 22316366
[TBL] [Abstract][Full Text] [Related]
51. Seminoma metastatic to the prostate resulting in a rectovesical fistula.
Plummer ER; Greene DR; Roberts JT
Clin Oncol (R Coll Radiol); 2000; 12(4):229-30. PubMed ID: 11005688
[TBL] [Abstract][Full Text] [Related]
52. Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients.
van den Hengel LG; van Steijn-van Tol AQ; Bertina RM; Versteeg HH; Osanto S
Thromb Res; 2013 Feb; 131(2):187-9. PubMed ID: 23260444
[No Abstract] [Full Text] [Related]
53. [Low dose COMPE. Cisplatin, vincristine, methotrexate, peplomycin, etoposide chemotherapy for advanced testicular cancer].
Ueda T; Yamauchi T; Kawai T; Ohono Y; Kawakami S; Yonese J
Nihon Hinyokika Gakkai Zasshi; 1994 Apr; 85(4):626-31. PubMed ID: 7514699
[TBL] [Abstract][Full Text] [Related]
54. Optimization of cisplatin doses in a testicular cancer patient with acute renal failure.
Pouliquen AL; Bousquet G; Le Maignan C; Bauer C; Lejri N; Misset JL; Lokiec F
J Oncol Pharm Pract; 2011 Sep; 17(3):265-9. PubMed ID: 19933251
[TBL] [Abstract][Full Text] [Related]
55. Intracellular Inclusions Detected in Stained Urinary Sediment.
Daae LNW; Andersen H
Clin Chem; 2017 May; 63(5):1048-1049. PubMed ID: 28455303
[No Abstract] [Full Text] [Related]
56. [A Case of Advanced Seminoma in a 79-Year-Old Man Successfully Treated with Etoposide and Cisplatin].
Shiga M; Kawai K; Kojyo K; Kurobe M; Ichioka D; Yoshino T; Ikeda A; Kojima T; Joraku A; Suetomi T; Tsutsumi M; Miyazaki J; Nishiyama H
Hinyokika Kiyo; 2015 Dec; 61(12):515-8. PubMed ID: 26790767
[TBL] [Abstract][Full Text] [Related]
57. Poor efficacy of BEP polychemotherapy in metastatic spermatocytic seminoma.
Horn T; Schulz S; Maurer T; Gschwend JE; Kübler HR
Med Oncol; 2011 Dec; 28 Suppl 1():S423-5. PubMed ID: 21086073
[TBL] [Abstract][Full Text] [Related]
58. Treatment of good-risk disseminated non-seminomatous germ cell tumours: the less bleomycin, the more cisplatin?
Culine S; Mahjoubi M; Philippot I; Droz JP
Eur J Cancer; 1991; 27(12):1715. PubMed ID: 1723608
[No Abstract] [Full Text] [Related]
59. [Early myocardial infarction associated with chemotherapy for testicular cancer].
Bernard P; Cellarier G; Crémades S; Gisserot O; De Jauréguiberry JP
Rev Med Interne; 2006 Jun; 27(6):497-8. PubMed ID: 16546304
[TBL] [Abstract][Full Text] [Related]
60. [Bleomycin-induced PSS-like pseudoscleroderma. Case report and review of the literature].
Behrens S; Reuther T; von Kobyletzki G; Kastner U; Dirschka T; Kerscher M; Altmeyer P
Hautarzt; 1998 Sep; 49(9):725-9. PubMed ID: 9794163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
